Dr David Cutter
Contact information
David Cutter
FRCR, DPhil
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined CTSU to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013 he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Recent publications
-
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.
Journal article
Frobisher C. et al, (2017), Br J Cancer, 117, 1723 - 1731
-
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
Journal article
Tseng YD. et al, (2017), Int J Radiat Oncol Biol Phys, 99, 825 - 842
-
Predicted Cardiac and Second Cancer Risks in Hodgkin Lymphoma Patients Treated With Advanced Proton Beam Therapy Compared to Photon Radiation Therapy
Conference paper
Ntentas G. et al, (2017), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99, S181 - S181
-
Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods
Conference paper
Ntentas G. et al, (2017), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99, E635 - E635
-
Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.
Journal article
Rugbjerg K. et al, (2017), Int J Cancer, 140, 2232 - 2245